Efficacy and Safety of Integrated Maxing Shigan Decoction and Azithromycin for Mycoplasma Pneumoniae Pneumonia in Children: A Systematic Review and Meta-Analysis

阿奇霉素 支原体肺炎 内科学 医学 科克伦图书馆 置信区间 随机对照试验 荟萃分析 肺炎 胃肠病学 肺炎支原体 传统医学 微生物学 生物 抗生素
作者
Qiong Huang,Qiong Zhang,Si Li
出处
期刊:Journal of Clinical Pharmacy and Therapeutics [Wiley]
卷期号:2023: 1-17
标识
DOI:10.1155/2023/2596562
摘要

Background. The primary objective of this study was to thoroughly assess the effectiveness of treating pediatric mycoplasma pneumoniae pneumonia (MPP) with Maxing Shigan decoction (MSD) and azithromycin. Materials and Methods. We comprehensively reviewed the literature for randomized controlled trials research on MPP treated by MSD combined with azithromycin in children in the databases of Medicine, Embase, ClinicalTrials.gov, Cochrane Library, PubMed, CNKI, WangFang, and VIP from inception to April 2021. dds ratio (OR) was used for dichotomous data, while the mean difference (MD) was adopted for continuous variables as effect size, both of which were demonstrated in effect size and 95% confidence intervals (CI). Results. A total of 49 studies with 5704 patients were included in the meta-analysis. The results showed that MSD combined with azithromycin significantly improved the clinical efficacy (OR = 5.31, 95% CI: (4.35, 6.49), and p < 0.001 ) and reduced the chest X-rays recovery time (MD = −2.25, 95% CI: (−2.86, −1.65), and p < 0.001 ), cough duration (MD = −2.53, 95% CI: (−2.93. −2.12), and p < 0.001 ), CRP (MD = −7.84, 95% CI: (−9.51, −6.17), and p < 0.001 ), fever duration (MD = −1.53, 95% CI: (−1.78, −1.28), and p < 0.001 ), hospital days (MD = −2.70, 95% CI: (−3.35, −2.06), and p < 0.001 ), moist rales duration (MD = −2.00, 95% CI: (−2.33, −1.68), and p < 0.001 ), and adverse effects (OR = 0.55, 95% CI: (0.41, 0.75), and p < 0.001 ) when compared with azithromycin alone in the treatment of MPP in children. Meta-regression analysis demonstrated that the course of disease and duration of medication contribute to the heterogeneity across studies when comparing outcomes between groups. Conclusion. MSD and azithromycin worked better when used in conjunction to treat MPP in young patients. These findings require confirmation by additional high-quality, big sample RCTs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
2秒前
思源应助缥缈南露采纳,获得10
2秒前
3秒前
Loga完成签到,获得积分20
3秒前
mumu完成签到,获得积分10
3秒前
打打应助张航采纳,获得10
4秒前
5秒前
lu完成签到,获得积分10
5秒前
yyzgyy发布了新的文献求助30
5秒前
曾经的朝雪完成签到 ,获得积分10
6秒前
123Y发布了新的文献求助10
6秒前
6秒前
6秒前
8秒前
8秒前
年轻的跳跳糖完成签到,获得积分10
9秒前
9秒前
silent发布了新的文献求助10
9秒前
Kevin63完成签到,获得积分10
10秒前
恒星七纪发布了新的文献求助10
11秒前
Huang发布了新的文献求助10
11秒前
帅气冰珍发布了新的文献求助10
12秒前
13秒前
13秒前
tomato大王发布了新的文献求助10
13秒前
ZHD发布了新的文献求助20
14秒前
15秒前
nito发布了新的文献求助10
15秒前
15秒前
可可爱钱完成签到,获得积分10
16秒前
Cherry发布了新的文献求助10
16秒前
aaaa应助zkx采纳,获得10
16秒前
帅气冰珍完成签到,获得积分10
17秒前
Fs应助ll采纳,获得200
18秒前
爆米花应助lll采纳,获得10
18秒前
顺其自然完成签到,获得积分10
18秒前
小蘑菇应助斯巴达采纳,获得10
18秒前
yi怡发布了新的文献求助10
18秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Arthritis and Related Conditions, An Issue of Orthopedic Clinics 1000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7288210
求助须知:如何正确求助?哪些是违规求助? 8907927
关于积分的说明 18853069
捐赠科研通 6957035
什么是DOI,文献DOI怎么找? 3208837
关于科研通互助平台的介绍 2378652
邀请新用户注册赠送积分活动 2184657